Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study

Shahriyar Shahbazi Khamas(Emma Kinderziekenhuis), Anke H. Maitland‐van der Zee(Utrecht University), Simone Hashimoto(Emma Kinderziekenhuis), Stephen J. Fowler(University of Manchester), Louise Fleming(Imperial College London), Mahmoud I. Abdel‐Aziz(GGD Amsterdam), Mario Gorenjak(University of Maribor), Uroš Potočnik, Olaia Sardón‐Prado(University of the Basque Country), Anne H. Neerincx(Amsterdam University Medical Centers), Sven‐Erik Dahlén(Karolinska University Hospital), Paolo Montuschi(Università Cattolica del Sacro Cuore), Susanne J. H. Vijverberg(Amsterdam University Medical Centers), Antoaneta A. Toncheva(University of Regensburg), Gunilla Hedlin(Karolinska University Hospital), Anna M. Hedman(Karolinska Institutet), Paula Corcuera(Biogipuzkoa Health Research Institute), Paul Brinkman(Respiratory Clinical Trials), Florian Singer(University Children’s Hospital Bern), Catarina Almqvist(Karolinska University Hospital), Aletta D. Kraneveld(Utrecht University), Maria Pino‐Yanes(Universidad de La Laguna), Susanne Brandstetter(University of Regensburg), Urs Frey(Boston Children's Hospital), Clare Murray(Manchester Academic Health Science Centre), Andrew Bush(British Lung Foundation), Ian M. Adcock(Imperial College London), Christine Wolff(University of Regensburg), Michael Kabesch(University Hospital Regensburg), Graham Roberts(St Mary's Hospital), Jelle M. Blankestijn(Emma Kinderziekenhuis), Javier Korta‐Murua(University of the Basque Country), Yoni Van Dijk(Emma Kinderziekenhuis), Susanne Harner(University of Regensburg), Wim van Aalderen(Emma Kinderziekenhuis), Klaus Bønnelykke(University of Copenhagen)
American Journal of Respiratory and Critical Care Medicine
April 22, 2024
Cited by 16


Related Papers